
    
      This is a single arm study to assess the effectiveness of an experimental telehealth
      intervention within the treatment of ESLD, and compare it with a historic cohort. All
      inpatients with advanced liver disease and at least 1 complication will be eligible to
      participate. the study group receives the Telehealth intervention and will be given an ipad
      preloaded with the instruments used for symptom monitoring and cognitive function assessment
      during the hospital admission.
    
  